Drug Chatter -- Tracking biopharma stock chatter

DrugPatentWatch - Biopharmaceutical Business Intelligence

Profile for DBV Technologies S.A. (DBVT)

« Back to company index

DBVT Chatter Timeline

Stock Ticker for DBVT

Most Active Tweeters for DBVT

UserTweets
@ConsumerFeed 2
@AmericanBanking 2
@SwingTradeBot 2
@portefeuillefun 1
@OlympiaReport 1

Recent Tweets for DBVT

firsttomarkets @firsttomarkets
DBV Technologies SA Initiated Coverage by Goldman Sachs (Ranked 28th) to Buy $DBVT #DBVT https://t.co/cKF5snpPEF
June 17th 2019, 11:06am
christrade10 @christrade10
RT @psk2329: $DBVT Goldman Sachs analyst Craig Suvannavejh started w/Buy rating and $14 price target. DBVT is a late-stage specialty biotec…
June 17th 2019, 8:06am
psk2329 @psk2329
$DBVT Goldman Sachs analyst Craig Suvannavejh started w/Buy rating and $14 price target. DBVT is a late-stage speci… https://t.co/FApYfBAUzZ
June 17th 2019, 8:06am
OlympiaReport @OlympiaReport
DBV TECHNOLOGIE/S $DBVT Rating Lowered to Sell at BidaskClub https://t.co/fGeLAef0km
June 17th 2019, 5:06am
SwingTradeBot @SwingTradeBot
Recent $DBVT technical alerts: Lower Bollinger Band Walk plus 3 more alerts... https://t.co/jBMxhHFfB3
June 16th 2019, 1:06pm
dispatchtribune @dispatchtribune
DBV TECHNOLOGIE/S $DBVT Stock Rating Upgraded by Zacks Investment Research https://t.co/6nwPkiDIgn
June 14th 2019, 2:06am
storminvestor @storminvestor
Zacks Investment Research Upgrades DBV TECHNOLOGIE/S $DBVT to Buy https://t.co/2WyQqghRCP #markets
June 12th 2019, 10:06pm
SleekMoneycom @SleekMoneycom
Zacks Investment Research Upgrades DBV TECHNOLOGIE/S $DBVT to Buy https://t.co/4vdatgeIDf #investing
June 12th 2019, 10:06pm
stocknewstimes @stocknewstimes
Zacks Investment Research Upgrades DBV TECHNOLOGIE/S $DBVT to Buy https://t.co/8AeLd0d5w8
June 12th 2019, 10:06pm
SwingTradeIdeas @SwingTradeIdeas
$DBVT - DBV Technologies S.A. (DBVT) Moves to Buy: Rationale Behind the Upgrade https://t.co/YMjHW04up0
June 12th 2019, 10:06am
WatchlistN @WatchlistN
DBV TECHNOLOGIE/S $DBVT Given Consensus Recommendation of “Hold” by Analysts https://t.co/FcAjQqPURp
June 11th 2019, 2:06am
AmericanBanking @AmericanBanking
DBV TECHNOLOGIE/S $DBVT Receives Average Rating of “Hold” from Analysts https://t.co/9MM8A9Xtre #stocks
June 11th 2019, 2:06am
ConsumerFeed @ConsumerFeed
-$0.68 EPS Expected for DBV TECHNOLOGIE/S $DBVT This Quarter https://t.co/DD3EWj3Inr
June 10th 2019, 12:06pm
SwingTradeBot @SwingTradeBot
Recent $DBVT technical alerts: Fell Below 20 DMA plus 12 more alerts... https://t.co/jBMxhHFfB3
June 8th 2019, 9:06am
TheMarketsDaily @TheMarketsDaily
-$0.68 EPS Expected for DBV TECHNOLOGIE/S $DBVT This Quarter https://t.co/gytB6yd14M
June 8th 2019, 5:06am
dakotafinancial @dakotafinancial
Zacks: Brokerages Expect DBV TECHNOLOGIE/S $DBVT to Post -$0.68 Earnings Per Share https://t.co/2uiHkmxP98
June 5th 2019, 6:06pm
AmericanBanking @AmericanBanking
-$0.68 Earnings Per Share Expected for DBV TECHNOLOGIE/S $DBVT This Quarter https://t.co/rV3xy4j9yg #stocks
June 5th 2019, 6:06pm
ConsumerFeed @ConsumerFeed
Reviewing Adaptimmune Therapeutics $ADAP & DBV TECHNOLOGIE/S $DBVT https://t.co/kHnEJWWTOP
June 4th 2019, 6:06pm
bihan35 @bihan35
RT @portefeuillefun: $AIMT $DBVT. New Data from Phase 3 PALISADE Follow-on Study of #AR101 for Peanut Allergy Show Continued Immunomodulati…
June 4th 2019, 7:06am
portefeuillefun @portefeuillefun
$AIMT $DBVT. New Data from Phase 3 PALISADE Follow-on Study of #AR101 for Peanut Allergy Show Continued Immunomodul… https://t.co/A5X3Cz5GMG
June 4th 2019, 7:06am
confcalltran @confcalltran
Report of foreign issuer [Rules 13a-16 and 15d-16] https://t.co/cGd4SSz1jz $DBVT
June 3rd 2019, 4:06pm
Stock_News_Now @Stock_News_Now
$DBVT: New SEC Filing for DBVT: Form 6-K (No. 0001193125-19-163521): https://t.co/5NXKCok9af
June 3rd 2019, 9:06am
1MinuteStock @1MinuteStock
Wondering about risks of $DBVT? The 63-day volatility is 26.19% https://t.co/bSXXNqW6KL
June 3rd 2019, 5:06am
1MinuteStock @1MinuteStock
Do you know that #WallStreet price for $DBVT is $19.3 https://t.co/lUlbP3t8v4
June 3rd 2019, 4:06am
biotechradar_eu @biotechradar_eu
$DBV Technologies $DBVT to Attend Upcoming Investor Conferences https://t.co/FiG7lTskO3
June 3rd 2019, 2:06am
NewsToDesk @NewsToDesk
$DBVT: DBV Technologies to Attend Upcoming Investor Conferences: https://t.co/v0neb5nHm2
June 3rd 2019, 1:06am
manu1r0 @manu1r0
DBV Technologies to Present Data from Epicutaneous Immunotherapy at EAACI 2019 https://t.co/9BdCSdmgX4 $DBVT
June 2nd 2019, 1:06pm
HottestStockNow @HottestStockNow
$DBVT to reveal findings for epicutaneous immunotherapy, the basis for its Viaskin technology platform https://t.co/Pe9imiKGbk
June 1st 2019, 8:06pm
1MinuteStock @1MinuteStock
Wondering about #sentiment indicator for $DBVT? The Short Ratio is 8.83% https://t.co/BUYXXmYd61
June 1st 2019, 11:06am
portefeuillefun @portefeuillefun
RT @biotechradar_eu: $DBV Technologies $DBVT to Present Data from Epicutaneous Immunotherapy at EAACI 2019 https://t.co/cqMV5ajU3h
June 1st 2019, 8:06am
biotechradar_eu @biotechradar_eu
$DBV Technologies $DBVT to Present Data from Epicutaneous Immunotherapy at EAACI 2019 https://t.co/cqMV5ajU3h
June 1st 2019, 8:06am
AnkurBanerjee17 @AnkurBanerjee17
RT @bio_clouseau: ICER evidence report on peanut allergy tx https://t.co/5DCgDhdx9R $AIMT $DBVT
May 29th 2019, 9:05am
bio_clouseau @bio_clouseau
ICER evidence report on peanut allergy tx https://t.co/5DCgDhdx9R $AIMT $DBVT
May 29th 2019, 8:05am
1MinuteStock @1MinuteStock
Wondering about risks of $DBVT? The 21-day volatility is 12.83% https://t.co/bSXXNqW6KL
May 27th 2019, 4:05am
MLTherapeutics @MLTherapeutics
ICER released draft report on $DBVT and $AIMT clinical effectiveness and value in treating #peanutallergy (if appro… https://t.co/8giGQjWz3U
May 26th 2019, 8:05am
HottestStockNow @HottestStockNow
$DBVT Makes Strategic Move https://t.co/Pe9imiKGbk
May 25th 2019, 4:05pm
dailypoliticaln @dailypoliticaln
DBV TECHNOLOGIE/S $DBVT Rating Increased to Hold at BidaskClub https://t.co/X8p0WYPMFn
May 25th 2019, 7:05am
macondailynews @macondailynews
DBV TECHNOLOGIE/S $DBVT Given Average Rating of “Hold” by Analysts https://t.co/oXOXA7nj0L
May 24th 2019, 7:05pm
Stock_News_Now @Stock_News_Now
$DBVT: New SEC Filing for DBVT: Form 6-K (No. 0001193125-19-157095): https://t.co/T9vUd88chN
May 24th 2019, 4:05pm
WatchlistN @WatchlistN
DBV TECHNOLOGIE/S $DBVT – Investment Analysts’ Weekly Ratings Changes https://t.co/dW835iuEfl
May 24th 2019, 9:05am
1MinuteStock @1MinuteStock
Unicorn Bay rating for $DBVT is 2.02 out of 5. https://t.co/V4GkRX3k2K
May 23rd 2019, 3:05am
ConsumerFeed @ConsumerFeed
DBV TECHNOLOGIE/S $DBVT Upgraded to Hold at BidaskClub https://t.co/Z3ApKp8uF1
May 23rd 2019, 2:05am
dakotafinancial @dakotafinancial
DBV TECHNOLOGIE/S $DBVT Receives Average Rating of “Hold” from Brokerages https://t.co/vWCSOtuMf3
May 22nd 2019, 12:05pm
WKRBNews @WKRBNews
Zacks: Brokerages Expect DBV TECHNOLOGIE/S $DBVT to Announce -$0.68 Earnings Per Share https://t.co/9zlOfMjsC4 #markets
May 22nd 2019, 12:05am
ZolmaxNews @ZolmaxNews
Aptose Biosciences $APTO & DBV TECHNOLOGIE/S $DBVT Head to Head Survey https://t.co/JBkhDxBjjm
May 21st 2019, 6:05am
WeekHerald @WeekHerald
DBV TECHNOLOGIE/S $DBVT Receives $13.04 Average Price Target from Brokerages https://t.co/OmtqZQcP6o
May 20th 2019, 6:05pm
dailypoliticaln @dailypoliticaln
DBV TECHNOLOGIE/S $DBVT Expected to Post Earnings of -$0.68 Per Share https://t.co/EHDiz6RI7t
May 19th 2019, 11:05pm
WKRBNews @WKRBNews
Critical Comparison: Aptose Biosciences $APTO & DBV TECHNOLOGIE/S $DBVT https://t.co/Io1vzp3iQS #markets
May 19th 2019, 4:05am
bulletin_en @bulletin_en
bluebird bio Inc. $DBVT Comparison side by side https://t.co/jCU4qutEMv
May 18th 2019, 4:05am
WatchlistN @WatchlistN
-$0.68 EPS Expected for DBV TECHNOLOGIE/S $DBVT This Quarter https://t.co/c5n3nV6zWP
May 17th 2019, 11:05am

DrugPatentWatch - Make Better Decisions
Contact © thinkBiotech LLC 2004 - 2019. All rights reserved.